REMISSION OF MYASTHENIA GRAVIS WITH MuSK Antibodies During Ruxolitinib Treatment

被引：12
作者：
Alboini, Paolo E. [1 ]
Evoli, Amelia [1 ]
Damato, Valentina [1 ]
Iorio, Raffaele [1 ]
Bartoccioni, Emanuela [2 ]
机构：
[1] Catholic Univ, Inst Neurol, Largo F Vito 1, I-00168 Rome, Italy
[2] Catholic Univ, Gen Pathol, Rome, Italy
来源：
MUSCLE & NERVE | 2017年 / 55卷 / 03期
关键词：
JAK/STAT; JAK/STAT inhibitors; MuSK; myasthenia gravis; myelofibrosis; ruxolitinib; JAK;
D O I：
10.1002/mus.25458
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：E12 / E13
页数：2
相关论文
共 7 条
[1]   Therapeutic Targeting of the JAK/STAT Pathway [J].
Aittomaki, Saara ;
Pesu, Marko .
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2014, 114 (01) :18-23
[2]   Involvement of JAK/STAT signaling in the pathogenesis of inflammatory bowel disease [J].
Coskun, Mehmet ;
Salem, Mohammad ;
Pedersen, Jannie ;
Nielsen, Ole Haagen .
PHARMACOLOGICAL RESEARCH, 2013, 76 :1-8
[3]   Remission of Recalcitrant Dermatomyositis Treated with Ruxolitinib [J].
Hornung, Thorsten ;
Janzen, Viktor ;
Wenzel, Joerg .
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (26) :2537-2538
[4]   JAK and STAT Signaling Molecules in Immunoregulation and Immune-Mediated Disease [J].
O'Shea, John J. ;
Plenge, Robert .
IMMUNITY, 2012, 36 (04) :542-550
[5]   Ruxolitinib: A Review of Its Use in Patients with Myelofibrosis [J].
Plosker, Greg L. .
DRUGS, 2015, 75 (03) :297-308
[6]   Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition [J].
Xing, Luzhou ;
Dai, Zhenpeng ;
Jabbari, Ali ;
Cerise, Jane E. ;
Higgins, Claire A. ;
Gong, Weijuan ;
de Jong, Annemieke ;
Harel, Sivan ;
DeStefano, Gina M. ;
Rothman, Lisa ;
Singh, Pallavi ;
Petukhova, Lynn ;
Mackay-Wiggan, Julian ;
Christiano, Angela M. ;
Clynes, Raphael .
NATURE MEDICINE, 2014, 20 (09) :1043-1049
[7]   Characterization of CD4 and CD8 T cell responses in MuSK myasthenia gravis [J].
Yi, J. S. ;
Guidon, A. ;
Sparks, S. ;
Osborne, R. ;
Juel, V. C. ;
Massey, J. M. ;
Sanders, D. B. ;
Weinhold, K. J. ;
Guptill, J. T. .
JOURNAL OF AUTOIMMUNITY, 2014, 52 :130-138
1